CHIR-98014 T2608
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
CHIR-98014 is a selective GSK3 inhibitor; potentiate insulin activation of glucose transport and utilization in vitro and in vivo.
CAS nr:
252935-94-7
Purity:
98%
Molecular Weight:
486,31
SMILES:
c1cc(c(cc1Cl)Cl)c1nc(ncc1n1ccnc1)NCCNc1nc(c(cc1)[N+](=O)[O-])N
Formula:
C20H17Cl2N9O2
Pathway:
PI3K/Akt/mTOR signaling,Angiogenesis,Stem Cells,Angiogenesis,Tyrosine Kinase/Adaptors,Tyrosine Kinase/Adaptors,PI3K/Akt/mTOR signaling,MAPK
Target:
GSK-3,Src,GSK-3,FGFR,Src,FGFR,S6 Kinase,S6 Kinase
